Postgastric bypass hypoglycaemia in a patient with end-stage renal disease: a diagnostic and management pitfall

BMJ Case Rep. 2017 Jun 15:2017:bcr2017220600. doi: 10.1136/bcr-2017-220600.

Abstract

Roux-en-Y gastric bypass (RYGB) surgery is currently one of the most popular procedures to aid weight loss. Hypoglycaemia associated with gastric bypass surgery is an underdiagnosed but life-threatening potential consequence of the surgical procedure. We present a case of a 44-year-old woman with end-stage renal disease presenting with refractory hypoglycaemia after 10 years of RYGB. Extensive history and work-up excluded medications, renal disease, insulinoma and dumping syndrome as the cause of hypoglycaemia. Dietary modifications or pharmacological trial of drugs did not ameliorate her symptoms with progressive worsening of hypoglycaemia leading to continuous dextrose infusion. Distal pancreatectomy was performed with subsequent resolution of hypoglycaemia. Surgical pathology results showed diffuse hyperplastic islet cells, confirming the diagnosis of postgastric bypass hypoglycaemia.

Keywords: Endocrinology; Gastroenterology; General practice / family medicine; Medical management; Pancreas and biliary tract.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diagnosis, Differential
  • Female
  • Gastric Bypass
  • Glucose / administration & dosage
  • Glucose / therapeutic use
  • Humans
  • Hypoglycemia / diagnosis*
  • Hypoglycemia / drug therapy
  • Hypoglycemia / surgery
  • Kidney Failure, Chronic*
  • Obesity, Morbid / surgery
  • Pancreatectomy
  • Postoperative Complications / diagnosis
  • Postoperative Complications / drug therapy
  • Postoperative Complications / surgery

Substances

  • Glucose